NDC 2019 on CNS tumors will review developments in understanding the molecular pathogenesis of pediatric brain tumors, and how more targeted therapies are improving life expectancy and quality of life.

Learning Objectives:

  1. Describe molecular advances in tumor classification.
  2. Better understand the evolution of targeted therapies.
  3. More clearly formulate a treatment plan for patients.

Impact Statements:

  1. New diagnostic strategies.
  2. Incorporating modern targeted therapies.
  3. Encouraging accrual to novel clinical trials.

2019 Videos